Protagonist Therapeutics, Inc — Director's Dealing 2018

Jun 1, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2018-05-21

Reporting Person: Saks Samuel R (Chief Development Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$17.66	2028-02-14	Common Stock (6000)		Direct

Footnotes

F1: The shares subject to the option shall vest in 12 equal monthly installments from the vesting commencement date of February 15, 2018.